Cancer process evaluation

A method of selecting a therapeutic agent to treat a cancer in a subject by at least one processor, the method comprising:

• receiving a plurality of protein data element values, each representing the level of a specific protein in a biological sample of said subject;
• classifying each protein data element as a member of one or more process classes, wherein each process class represents a specific mechanism of cancer treatment resistance;
• for each process class, calculating a first process score as a Euclidean distance of a vector whose components are each derived from respective member protein data element values, wherein the first process score represents prominence of the respective process class to cancer treatment resistance;
• selecting at least one therapeutic agent that targets a selected process class, wherein said process class is selected based on said process class's first process score;
• and
• administering said selected at least one therapeutic agent to said subject.